About
PI3K/mTOR inhibitors
Areas of Focus
Categories
Small Molecule Pharmaceutical
Clinical Trials (1)
View allTotal Trials
1
As Lead Sponsor
1
As Collaborator
0
Total Enrollment
46
By Phase
PHASE2: 1
By Status
COMPLETED: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2023
2024
2025
2026
Today
Hover over trial bars to see details
Locations (1)
Headquarters
Basel, Switzerland
Map
Loading map...